Bayer

Bayer looks to expand Kerendia label to include heart failure
Clinical Trials Arena
Fri, 09/1/23 - 12:38 pm
Bayer
Kerendia
clinical trials
heart failure
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
MedCity News
Mon, 08/28/23 - 08:21 pm
Bayer
cell therapy
Parkinson's Disease
clinical trials
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Fierce Biotech
Mon, 08/28/23 - 11:37 am
Bayer
Parkinson's Disease
cell therapy
bemdaneprocel
BlueRock Therapeutics
Bayer's digital drive in consumer health gathers pace
Pharmaphorum
Wed, 08/23/23 - 10:08 am
Bayer
consumer health
digital health
Mahana Therapeutics
Bayer pledges $500K in drugs and cash relief to Maui following devastating wildfires
Fierce Pharma
Thu, 08/17/23 - 11:35 pm
Bayer
Hawaii
Maui
wildfires
donations
Bayer-bought BlueRock cuts 12% of workforce across 3 sites as pipeline contracts
Fierce Biotech
Thu, 08/17/23 - 11:32 pm
BlueRock Therapeutics
Parkinson's Disease
Bayer
layoffs
With sales in free fall, Bayer's new CEO Anderson considers structural change
Fierce Pharma
Tue, 08/8/23 - 10:34 pm
Bayer
Pharma CEOs
Bill Anderson
Bayer ends respiratory distress drug development in latest phase 2 cleanout
Fierce Pharma
Tue, 08/8/23 - 10:21 am
Bayer
adrenomedullin pegol
earnings
ARDS
Bayer expects gloomier 2023 as lower glyphosate sales bolster breakup advocates' case
Fierce Pharma
Tue, 07/25/23 - 11:56 am
Bayer
earnings
Check out the most-seen pharma brand TV debuts of 2023
Medical Marketing and Media
Wed, 07/19/23 - 05:49 pm
TV ads
DTC advertising
Bayer
AbbVie
Bristol Myers Squibb
Bayer's Parkinson's cell therapy passes early clinical safety test, clearing path to phase 2
Fierce Biotech
Wed, 06/28/23 - 10:05 am
Bayer
Parkinson's Disease
clinical trials
cell therapy
bemdaneprocel
Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says
Fierce Pharma
Mon, 06/12/23 - 11:22 pm
Bayer
oncology
M&A
Bayer licenses lipid nanoparticle tech for gene therapy
BioProcess International
Wed, 06/7/23 - 10:17 am
Bayer
Acuitas Therapeutics
gene editing
Bayer launches precision health unit in latest digital health venture
BioPharma Dive
Fri, 06/2/23 - 10:12 am
Bayer
consumer health
digital health
precision health
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
BioSpace
Thu, 06/1/23 - 06:43 pm
Bayer
Cedilla Therapeutics
CyclinE1/CDK2 inhibitors
oncology
precision oncology
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Bayer's acting BD chief lobbies for the job the only way he knows how: by making deals
Fierce Biotech
Wed, 05/24/23 - 10:23 am
Bayer
business development
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Tue, 05/23/23 - 06:20 pm
Astellas
Iveric Bio
Bayer
Amgen
M&A
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
FDA
drug approvals
accelerated approvals
AbbVie
AstraZeneca
Bayer
Bristol Myers Squibb
JNJ
Merck
Merck KGaA
Novartis
Pfizer
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
BioSpace
Wed, 05/10/23 - 10:04 am
Bayer
Bicycle Therapeutics
drug development
radiopharmaceuticals

Pages